CBD of Denver (CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis. Through its brands, Rockflowr and BlackPearlCBD, CBDD has built a strong customer base by focusing on top quality products and meaningful customer relationships.

CBDD is successfully executing its M&A strategy to acquire, grow, and support Swiss cannabis companies and is expected to grow significantly faster than already impressive industry growth rates. CBD companies operating in Europe trade for an average 12.4x price-to-sales multiple. Currently, based on 2020 unaudited proforma results, CBDD is trading at just over 6x sales. The Swiss cannabis industry is expected to grow to $2.7 billion by 2028 and CBDD’s growing foothold in this market provides a unique “Swiss quality” advantage that the Company plans to leverage as it expands into other lucrative markets in the EU and beyond. The Company continues to expand its product portfolio with a specific focus on higher-margin products. CBDD is expected to report audited results in the near-term, providing the necessary transparency to expand investor interest and drive valuation improvement in-line with the Company’s continued performance.

  • Strong foundation for rapid revenue growth
    • Expects to report $15M revenue (proforma) for 2020
    • Projecting $22M revenue in 2021 with $2.5-$3M EBITDA

  • Swiss cannabis industry expected to grow to $2.7B by 2028
    • Cannabis market still in infancy in Switzerland and EU
    • Strong, exclusive distribution partnerships in EU

  • Expanding portfolio of new products and markets
    • Near-term expansion into EU

  • Experienced and diverse management team

  • “Swiss quality” branding provides competitive advantage

  • Successfully pursuing M&A strategy to acquire, grow, and support Swiss cannabis companies